Intensive Course in Genetic Cancer Risk Assessment

The Intensive Course 2023 application is now closed

  • The IC 2023 session will start October 21, 2022, and will end February 24, 2023.
  • The enrollment window for IC 2023 is closed, and the course is full. The IC 2024 application will be open from April 2023 to August 2023.
The Intensive Course in Genomic Cancer Risk Assessment is a continuing medical education course for Physicians, Physician Assistants, Genetic Counselors, Master's or PhD in Genetics or Advanced Practice Nurses, and Geneticists.
The course runs from October through February each year. Track 1 of the course combines distance learning with a four-day series of live online workshops, and Track 2 offers online distance-learning only. The only difference between the two tracks is that Track 1 offers four days of intensive virtual workshops.
For course or application inquiries, visit the webpage.

Learning Outcomes

At the conclusion of the Intensive Course in Genomic Cancer Risk Assessment, participants will be able to:
  • Integrate cancer genetics and oncology knowledge into clinical practice
  • Apply skills commensurate with practitioner-level proficiency into the cancer risk assessment and case management process
  • Recommend risk-appropriate options for cancer surveillance and prevention as part of the cancer risk assessment, including imaging, chemopreventive and surgical interventions
  • Incorporate understanding of medical, ethical, legal, and psychosocial ramifications of cancer risk counseling and testing into clinical practice and research collaboration
  • Examine the value of hereditary cancer registries, cancer epidemiology and cancer prevention studies for patients and clinicians
  • Realize greater professional self-efficacy related to genetic cancer risk assessment skills
  • Incorporate Web-based resources into ongoing practice-based education, professional development, and research support
  • Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics)
Alumni of the course have the option to join our Clinical Cancer Genomics Community of Practice, a network currently numbering more than 1,000 clinicians, and to participate in our Clinical Cancer Genomics Community Research Network.

Contact Us

To learn more about the Intensive Course in Genomic Cancer Risk Assessment, contact us at